This topic contains a solution. Click here to go to the answer

Author Question: In chronic drug users, biological changes in the neural pathways can alter responsiveness to ... (Read 48 times)

mynx

  • Hero Member
  • *****
  • Posts: 555
In chronic drug users, biological changes in the neural pathways can alter responsiveness to non-drug environmental stimuli.
 
  a. True
  b. False
  Indicate whether the statement is true or false

Question 2

Acetylcholine is a neurotransmitter that is released at the neuromuscular junction.
 
  a. True
  b. False
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

emsimon14

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

True

Answer to Question 2

True




mynx

  • Member
  • Posts: 555
Reply 2 on: Jun 22, 2018
YES! Correct, THANKS for helping me on my review


LVPMS

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

A recent study has found that following a diet rich in berries may slow down the aging process of the brain. This diet apparently helps to keep dopamine levels much higher than are seen in normal individuals who do not eat berries as a regular part of their diet as they enter their later years.

Did you know?

Nitroglycerin is used to alleviate various heart-related conditions, and it is also the chief component of dynamite (but mixed in a solid clay base to stabilize it).

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library